Last reviewed · How we verify
ALRN-6924 in combination with cytarabine
ALRN-6924 in combination with cytarabine is a Small molecule drug developed by Aileron Therapeutics, Inc.. It is currently in Phase 1 development. Also known as: ALRN-6924 in combination with Ara-C.
At a glance
| Generic name | ALRN-6924 in combination with cytarabine |
|---|---|
| Also known as | ALRN-6924 in combination with Ara-C |
| Sponsor | Aileron Therapeutics, Inc. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Phase 1 Study of the Dual MDM2/MDMX Inhibitor ALRN-6924 in Pediatric Cancer (PHASE1)
- Safety Study of ALRN-6924 in Patients With Acute Myeloid Leukemia or Advanced Myelodysplastic Syndrome (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- ALRN-6924 in combination with cytarabine CI brief — competitive landscape report
- ALRN-6924 in combination with cytarabine updates RSS · CI watch RSS
- Aileron Therapeutics, Inc. portfolio CI
Frequently asked questions about ALRN-6924 in combination with cytarabine
What is ALRN-6924 in combination with cytarabine?
ALRN-6924 in combination with cytarabine is a Small molecule drug developed by Aileron Therapeutics, Inc..
Who makes ALRN-6924 in combination with cytarabine?
ALRN-6924 in combination with cytarabine is developed by Aileron Therapeutics, Inc. (see full Aileron Therapeutics, Inc. pipeline at /company/aileron-therapeutics-inc).
Is ALRN-6924 in combination with cytarabine also known as anything else?
ALRN-6924 in combination with cytarabine is also known as ALRN-6924 in combination with Ara-C.
What development phase is ALRN-6924 in combination with cytarabine in?
ALRN-6924 in combination with cytarabine is in Phase 1.
Related
- Manufacturer: Aileron Therapeutics, Inc. — full pipeline
- Also known as: ALRN-6924 in combination with Ara-C
- Compare: ALRN-6924 in combination with cytarabine vs similar drugs
- Pricing: ALRN-6924 in combination with cytarabine cost, discount & access